Symbiotec
APAC
Indore
,
India
Established
FOUNDED
1995
HEADCOUNT
1001-5000
FUNDING
Growth / PE-backed
Keywords:
CDMO, fermentation, precision_fermentation, biocatalysis, therapeutics
BUSINESS
Founded in 1995 (incorporated 2002) in Indore, Madhya Pradesh, India. Symbiotec is one of the world's largest vertically integrated manufacturers of corticosteroid and steroidal hormone active pharmaceutical ingredients (APIs), with a global volume market share leadership position and presence across the top 10 corticosteroid and steroidal hormone API categories. The company has approximately 1,800 employees, $49 million in annual revenue, and 700 KL of fermentation capacity supporting biotransformation and biosynthesis platforms plus 585 MT of chemical synthesis capacity. In April 2025, Symbiotec commissioned a new $40 million biomanufacturing hub in Indore (Phase I: 4 x 100 KL fermenters) focused on fermentation-based manufacturing for pharmaceuticals, alternative proteins, nutraceuticals, and bioactives, positioning itself as a CDMO for the broader bioeconomy.
BIOTECH INVOLVEMENT
Fermentation and biotransformation are core to Symbiotec's existing steroid API business, where microbial conversion steps are used in multi-step synthesis of corticosteroids and hormones. The new biomanufacturing hub explicitly targets precision fermentation and recombinant technology for non-pharmaceutical markets including alternative proteins, nutraceuticals, and bioactives, representing a strategic expansion from pharma into industrial biotechnology CDMO services.
TECHNOLOGY PLATFORM
fermentation; biotransformation; precision fermentation
PRIMARY PRODUCTS
Corticosteroid APIs; steroidal-hormone APIs; fermentation-based APIs; complex injectables